Javascript must be enabled to continue!
L26/P-123 When morphology is not enough: interaction of blastulation timing and morphology in euploid embryo transfer outcomes
View through CrossRef
Abstract
Study question
In elective single euploid blastocyst transfers, does delayed blastulation modify the prognostic value of morphology for pregnancy outcomes?
Summary answer
Delayed blastulation attenuates the prognostic value of morphology, with some Day-6 euploid embryos showing outcomes comparable to lower-grade Day-5 embryos.
What is known already
Although euploid embryos are recognized to differ in implantation potential, guidance on embryo prioritization when morphology and blastulation timing conflict remains limited. Blastocyst morphology and day of development independently predict outcomes in unselected embryos, yet their interaction within euploid-only cohorts is less clearly defined. Existing studies often assess these parameters in isolation and provide limited support for clinical decision-making when delayed blastulation accompanies favorable morphology.
Study design, size, duration
Retrospective observational study (2014–2024) including 613 elective single euploid frozen embryo transfers. Only self-gamete IVF/ICSI cycles with blastocyst biopsy, NGS-based PGT-A, and euploid transfer were included; donor cycles, non-euploid transfers, and fresh transfers were excluded. Transfers were stratified by day of blastulation (Day-5: n = 560; Day-6: n = 53) and subdivided by Gardner morphology grades.
Participants/materials, setting, methods
Blastocysts expanding on Day-5 or Day-6 underwent trophectoderm biopsy followed by vitrification using a freeze-all strategy. Genetic screening was performed using NGS, and only euploid embryos were transferred in frozen embryo transfer cycles. Elective single euploid transfers with 100% post-warming survival were included. Implantation, miscarriage, and live birth outcomes were compared across morphology grades and blastulation timing.
Main results and the role of chance
Main results and the role of chance (≤200 words)Among 560 Day-5 euploid blastocyst transfers, implantation and live birth rates declined progressively with worsening morphology, from approximately 75% in AA-grade embryos to 50% in CC-grade embryos, demonstrating a significant dose–response relationship (p for trend <0.05). Miscarriage rates increased with declining morphology, although not all comparisons reached statistical significance.In the Day-6 cohort (n = 53), pregnancy outcomes were consistently lower across morphology grades compared with Day-5 transfers. Within-grade comparisons showed significantly reduced live birth rates for Day-6 BC-grade embryos (n = 20) compared with Day-5 BC embryos (p = 0.013), while CC-grade embryos (Day-6 n = 24) showed a borderline reduction (p = 0.051). Across comparable grades, Day-6 blastocysts exhibited an absolute reduction of approximately 20–30% in live birth rates, driven by lower implantation and higher miscarriage rates. Notably, high-grade Day-6 blastocysts did not consistently outperform lower-grade Day-5 embryos, highlighting a clinically relevant trade-off frequently encountered in practice. Analyses were stratified by blastulation day to account for unequal group sizes reflecting routine clinical distribution.
Limitations, reasons for caution
This retrospective single-center analysis is limited by imbalance between Day-5 and Day-6 sample sizes and small Day-6 subgroups, reducing statistical power. Findings should be interpreted as hypothesis-refining rather than practice-changing.
Wider implications of the findings
These data do not propose a new selection algorithm but provide confirmatory evidence that blastulation timing should be considered alongside morphology when prioritizing euploid embryos. The findings may support counseling and transfer decisions when morphology and developmental timing present competing signals.
Trial registration number
No
Oxford University Press (OUP)
Title: L26/P-123 When morphology is not enough: interaction of blastulation timing and morphology in euploid embryo transfer outcomes
Description:
Abstract
Study question
In elective single euploid blastocyst transfers, does delayed blastulation modify the prognostic value of morphology for pregnancy outcomes?
Summary answer
Delayed blastulation attenuates the prognostic value of morphology, with some Day-6 euploid embryos showing outcomes comparable to lower-grade Day-5 embryos.
What is known already
Although euploid embryos are recognized to differ in implantation potential, guidance on embryo prioritization when morphology and blastulation timing conflict remains limited.
Blastocyst morphology and day of development independently predict outcomes in unselected embryos, yet their interaction within euploid-only cohorts is less clearly defined.
Existing studies often assess these parameters in isolation and provide limited support for clinical decision-making when delayed blastulation accompanies favorable morphology.
Study design, size, duration
Retrospective observational study (2014–2024) including 613 elective single euploid frozen embryo transfers.
Only self-gamete IVF/ICSI cycles with blastocyst biopsy, NGS-based PGT-A, and euploid transfer were included; donor cycles, non-euploid transfers, and fresh transfers were excluded.
Transfers were stratified by day of blastulation (Day-5: n = 560; Day-6: n = 53) and subdivided by Gardner morphology grades.
Participants/materials, setting, methods
Blastocysts expanding on Day-5 or Day-6 underwent trophectoderm biopsy followed by vitrification using a freeze-all strategy.
Genetic screening was performed using NGS, and only euploid embryos were transferred in frozen embryo transfer cycles.
Elective single euploid transfers with 100% post-warming survival were included.
Implantation, miscarriage, and live birth outcomes were compared across morphology grades and blastulation timing.
Main results and the role of chance
Main results and the role of chance (≤200 words)Among 560 Day-5 euploid blastocyst transfers, implantation and live birth rates declined progressively with worsening morphology, from approximately 75% in AA-grade embryos to 50% in CC-grade embryos, demonstrating a significant dose–response relationship (p for trend <0.
05).
Miscarriage rates increased with declining morphology, although not all comparisons reached statistical significance.
In the Day-6 cohort (n = 53), pregnancy outcomes were consistently lower across morphology grades compared with Day-5 transfers.
Within-grade comparisons showed significantly reduced live birth rates for Day-6 BC-grade embryos (n = 20) compared with Day-5 BC embryos (p = 0.
013), while CC-grade embryos (Day-6 n = 24) showed a borderline reduction (p = 0.
051).
Across comparable grades, Day-6 blastocysts exhibited an absolute reduction of approximately 20–30% in live birth rates, driven by lower implantation and higher miscarriage rates.
Notably, high-grade Day-6 blastocysts did not consistently outperform lower-grade Day-5 embryos, highlighting a clinically relevant trade-off frequently encountered in practice.
Analyses were stratified by blastulation day to account for unequal group sizes reflecting routine clinical distribution.
Limitations, reasons for caution
This retrospective single-center analysis is limited by imbalance between Day-5 and Day-6 sample sizes and small Day-6 subgroups, reducing statistical power.
Findings should be interpreted as hypothesis-refining rather than practice-changing.
Wider implications of the findings
These data do not propose a new selection algorithm but provide confirmatory evidence that blastulation timing should be considered alongside morphology when prioritizing euploid embryos.
The findings may support counseling and transfer decisions when morphology and developmental timing present competing signals.
Trial registration number
No.
Related Results
Non-invasive, label-free optical analysis to detect aneuploidy within the inner cell mass of the preimplantation embryo
Non-invasive, label-free optical analysis to detect aneuploidy within the inner cell mass of the preimplantation embryo
Abstract
Study question
Can label-free, non-invasive optical imaging by hyperspectral microscopy discern between euploid and an...
O-274 An Artificial Intelligence (AI) based screening test can reliably predict embryo ploidy
O-274 An Artificial Intelligence (AI) based screening test can reliably predict embryo ploidy
Abstract
Study question
Can calibrated AI ploidy screening test results provide reliable, biologically-justified estimates of em...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Day 3 embryo morphology are critical predictors for euploid blastocyst
Day 3 embryo morphology are critical predictors for euploid blastocyst
Abstract
Purpose: To determine whether day 3 or day 1 embryo morphologic grading affected euploid blastocyst rate in PGT cycle.Methods: 2001 embryos were obtained from 219 ...
P-206 Could day 7 embryo culture become standard practice to improve patients’ treatment and outcome?
P-206 Could day 7 embryo culture become standard practice to improve patients’ treatment and outcome?
Abstract
Study question
What are the clinical outcomes following transfer of day 7 embryos; could day 7 embryo culture become pa...
Non-invasive, label-free optical analysis to detect aneuploidy within the inner cell mass of the preimplantation embryo
Non-invasive, label-free optical analysis to detect aneuploidy within the inner cell mass of the preimplantation embryo
Abstract
STUDY QUESTION
Can label-free, non-invasive optical imaging by hyperspectral autofluorescence microscopy discern...
P-387 Autologous Platelet-Rich Plasma (PRP) intrauterine infusion before embryo transfer could improve the treatment outcomes, especially for transferring euploid blastocysts, in recurrent implantation failure patients
P-387 Autologous Platelet-Rich Plasma (PRP) intrauterine infusion before embryo transfer could improve the treatment outcomes, especially for transferring euploid blastocysts, in recurrent implantation failure patients
Abstract
Study question
Is the intrauterine infusion of autologous PRP prior to embryo transfer, especially euploid blastocyst t...
Endometrial immune assessment in patients with a history of previous euploid blastocyst failure
Endometrial immune assessment in patients with a history of previous euploid blastocyst failure
BackgroundInflux and establishment of key endometrial immune factors in the mid-luteal phase of the menstrual cycle is paramount for successful embryo implantation. Endometrial imm...

